is a microarray for the diagnosis of Familial Hypercholesterolemia and was released in Europe in June 2004 to become the first CE-marked DNA microarray for routine clinical diagnosis.
Low density DNA-chip able to detect more than 120 mutations in the LPL gene.Allows the establishment of a definite diagnosis of LPLD, identifying patients who may benefit from gene therapy for LPLD .AMT
Under construction
With the collaboration of:
